AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22384612 — intervention group
Group type: COMPARATOR
Intervention: Standard doses of hMG (control group)
Number of subjects: 139
Study 19885943 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint stimulation intervention for quitting smoking
Number of subjects: 59
Study 19885943 — intervention group
Group type: COMPARATOR
Intervention: Sham acupoint intervention
Number of subjects: 59
Study 17416005 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon ion radiotherapy (C-ion RT)
Number of subjects: 5
Study 17416005 — intervention group
Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 5
Study 12734766 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 12
Study 11122888 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dose intensity during induction therapy
Number of subjects: 1200
Study 11122888 — intervention group
Group type: EXPERIMENTAL
Intervention: Related-donor allogeneic bone marrow transplantation
Number of subjects: 1200
Study 11122888 — intervention group
Group type: COMPARATOR
Intervention: Purged autologous bone marrow transplantation and standard chemotherapy consolidation
Number of subjects: 1200
Study 11122888 — intervention group
Group type: COMPARATOR
Intervention: Autologous transplantation and chemotherapy
Number of subjects: 1200
Study 9052515 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 10
Study 9052515 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 10
Study 9052515 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 10
Study 9052515 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 10
Study 8333807 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 300
Study 8333807 — intervention group
Group type: COMPARATOR
Intervention: Recumbent position
Number of subjects: 300
Study 8333807 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position (symptomatic patients)
Number of subjects: 300
Study 8333807 — intervention group
Group type: EXPERIMENTAL
Intervention: History of fainting (symptomatic patients)
Number of subjects: 300
Study 3571768 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitolterol mesylate, 1.0 mg, administered three times daily for 3 months
Number of subjects: 182
Study 3571768 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol hydrochloride, 1.5 mg, administered three times daily for 3 months
Number of subjects: 182
Study 3571768 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitolterol mesylate
Number of subjects: 182
Study 3571768 — intervention group
Group type: COMPARATOR
Intervention: Isoproterenol hydrochloride
Number of subjects: 182
Study 3571768 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 182
Study 29540327 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 200
Study 29540327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 27054529 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 110
Study 27054529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 24595613 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-subvastus approach (group I)
Number of subjects: 68
Study 24595613 — intervention group
Group type: COMPARATOR
Intervention: Standard approach (group II)
Number of subjects: 68
Study 23059436 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 92
Study 20332388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (classroom sessions promoting sun protection and provision of two free wide-brimmed hats)
Number of subjects: 2491
Study 20332388 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 2491
Study 20332388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (self-reported hat use outside of school)
Number of subjects: 2491
Study 20332388 — intervention group
Group type: COMPARATOR
Intervention: Control (self-reported hat use outside of school)
Number of subjects: 2491
Study 20332388 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (skin pigmentation measurements)
Number of subjects: 2491
Study 20332388 — intervention group
Group type: COMPARATOR
Intervention: Control (skin pigmentation measurements)
Number of subjects: 2491
Study 18302679 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% minocycline hydrochloride ointment applied once into the pocket
Number of subjects: 91
Study 18302679 — intervention group
Group type: COMPARATOR
Intervention: Sterilized physiological saline irrigation
Number of subjects: 91
Study 15672057 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic variceal ligation
Number of subjects: 73
Study 15672057 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic sclerotherapy
Number of subjects: 73
Study 12846762 — intervention group
Group type: EXPERIMENTAL
Intervention: Kt/V target group A (1.5 to 1.7)
Number of subjects: 320
Study 12846762 — intervention group
Group type: EXPERIMENTAL
Intervention: Kt/V target group B (1.7 to 2.0)
Number of subjects: 320
Study 12846762 — intervention group
Group type: EXPERIMENTAL
Intervention: Kt/V target group C (>2.0)
Number of subjects: 320
Study 12846762 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Kt/V
Number of subjects: 320
Study 12846762 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum albumin and CNI scores
Number of subjects: 320
Study 12846762 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) treatment
Number of subjects: 320
Study 12846762 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall 2-year patient survival
Number of subjects: 320
Study 10761820 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0
Study 10761820 — intervention group
Group type: COMPARATOR
Intervention: Other antipsychotic drugs
Number of subjects: 0
Study 8872633 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiorphan (inhaled, 0.5 ml containing 1.25 mg/ml, administered by two inhalations)
Number of subjects: 13
Study 8872633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 1997056 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 110
Study 1997056 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 110
Study 1997056 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% ropivacaine
Number of subjects: 110
Study 1997056 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 110
Study 1997056 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine
Number of subjects: 110
Study 1997056 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ropivacaine and bupivacaine at the same concentration
Number of subjects: 110
Study 1997056 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 110
Study 6858932 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg/day
Number of subjects: 20
Study 6858932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30012527 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT-DIBH
Number of subjects: 62
Study 30012527 — intervention group
Group type: COMPARATOR
Intervention: Standard radiotherapy
Number of subjects: 62
Study 26948543 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) - 4 × 4 min at 90%-95% of maximal heart rate, three times a week, 120 min/week, n=24
Number of subjects: 47
Study 26948543 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Exercise (MIE) - 210 min/week, n=23
Number of subjects: 47
Study 26948543 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention), N=37
Number of subjects: 47
Study 24268702 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic electrocautery of the ovaries
Number of subjects: 168
Study 24268702 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropins
Number of subjects: 168
Study 22640924 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-preference, stepped care protocol for depression
Number of subjects: 0
Study 22640924 — intervention group
Group type: COMPARATOR
Intervention: Referred care arm decided by primary care provider
Number of subjects: 0
Study 20452781 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea ingestion (3 breakfast cups, 540 ml total)
Number of subjects: 10
Study 19090602 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscous fiber blend biscuits (10 g of highly viscous fiber blend)
Number of subjects: 19
Study 19090602 — intervention group
Group type: COMPARATOR
Intervention: Control biscuits (50 g available carbohydrates)
Number of subjects: 19
Study 19090602 — intervention group
Group type: COMPARATOR
Intervention: White bread with 12 g of margarine
Number of subjects: 19
Study 19090602 — intervention group
Group type: COMPARATOR
Intervention: White bread alone
Number of subjects: 19
Study 15951457 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient‐specific, evidence‐based decision aid
Number of subjects: 386
Study 15951457 — intervention group
Group type: COMPARATOR
Intervention: Usual care (informational pamphlet)
Number of subjects: 386
Study 12947360 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic syndrome
Number of subjects: 425
Study 12947360 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering medication
Number of subjects: 425
Study 12947360 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 425
Study 10783843 — intervention group
Group type: EXPERIMENTAL
Intervention: Braun Oral‐B Ultra Plaque Remover (D9)
Number of subjects: 23
Study 10783843 — intervention group
Group type: COMPARATOR
Intervention: Philips/Jordan HP 735
Number of subjects: 23
Study 9863160 — intervention group
Group type: EXPERIMENTAL
Intervention: E2‐WTCDS
Number of subjects: 18
Study 9863160 — intervention group
Group type: COMPARATOR
Intervention: E2‐TTS (control)
Number of subjects: 18
Study 2068950 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D3 (2 micrograms)
Number of subjects: 7
Study 2068950 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (10 mg)
Number of subjects: 7
Study 2068950 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D3 (2 micrograms) + Prednisone (10 mg)
Number of subjects: 7
Study 2068950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 6631978 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of sexual awareness, relaxation and breathing (SARB group)
Number of subjects: 0
Study 6631978 — intervention group
Group type: COMPARATOR
Intervention: Pubococcygeal exercises (PC group)
Number of subjects: 0
Study 31378962 — intervention group
Group type: EXPERIMENTAL
Intervention: moxifloxacin
Number of subjects: 20
Study 31378962 — intervention group
Group type: EXPERIMENTAL
Intervention: dofetilide
Number of subjects: 20
Study 31378962 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 20
Study 31378962 — intervention group
Group type: EXPERIMENTAL
Intervention: dolasetron
Number of subjects: 20
Study 31378962 — intervention group
Group type: EXPERIMENTAL
Intervention: quinine
Number of subjects: 20
Study 31378962 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 31378962 — intervention group
Group type: EXPERIMENTAL
Intervention: levocetirizine
Number of subjects: 20
Study 30665339 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored Cooperative High-Intensity Interval Training (C-HIIT)
Number of subjects: 158
Study 30665339 — intervention group
Group type: COMPARATOR
Intervention: Static stretching (Control)
Number of subjects: 158
Study 27686663 — intervention group
Group type: EXPERIMENTAL
Intervention: Mydrin eye-drops (tropicamide and phenylephrine hydrochloride)
Number of subjects: 60
Study 27373438 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF6001 400 μg
Number of subjects: 36
Study 27373438 — intervention group
Group type: EXPERIMENTAL
Intervention: CHF6001 1200 μg
Number of subjects: 36
Study 27373438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 24725800 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 33
Study 24725800 — intervention group
Group type: COMPARATOR
Intervention: Trigger point compression technique (TCT)
Number of subjects: 33
Study 22428941 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher consultation and coaching program (training + consultation/coaching)
Number of subjects: 364
Study 22428941 — intervention group
Group type: COMPARATOR
Intervention: Training only (Control)
Number of subjects: 364
Study 19146755 — intervention group
Group type: EXPERIMENTAL
Intervention: Line-probe assay (LiPA) for rapid detection of rifampicin resistance
Number of subjects: 143
Study 19146755 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug susceptibility testing (DST)
Number of subjects: 143
Study 17469130 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 325
Study 17469130 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy smoking (total of >20 pack-years)
Number of subjects: 325
Study 17469130 — intervention group
Group type: COMPARATOR
Intervention: Former smokers and those who had never smoked
Number of subjects: 325
Study 17469130 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 325
Study 11195234 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cisapride (0.1 mg/kg given 8 hourly)
Number of subjects: 20
Study 11195234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9124832 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily primaquine (0.5 mg of base per kg of body weight per day)
Number of subjects: 129
Study 9124832 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly chloroquine (300 mg of base one time per week)
Number of subjects: 129
Study 9124832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 1559542 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF (8 micrograms kg‐1) via intravenous (i.v.) bolus injection
Number of subjects: 0
Study 1559542 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGM-CSF (8 micrograms kg‐1) via subcutaneous (s.c.) bolus injection
Number of subjects: 0
Study 3888863 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam 20 mg daily
Number of subjects: 24
Study 3888863 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 1000 mg daily
Number of subjects: 24
Study 3888863 — intervention group
Group type: COMPARATOR
Intervention: Pre-trial medication
Number of subjects: 24
Study 31372796 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive online learning module
Number of subjects: 114
Study 31372796 — intervention group
Group type: COMPARATOR
Intervention: High interactivity
Number of subjects: 114
Study 31372796 — intervention group
Group type: COMPARATOR
Intervention: Low interactivity
Number of subjects: 114
Study 29174115 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg ponesimod
Number of subjects: 326
Study 29174115 — intervention group
Group type: EXPERIMENTAL
Intervention: 40mg ponesimod
Number of subjects: 326
Study 29174115 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study 29174115 — intervention group
Group type: EXPERIMENTAL
Intervention: Predicted 10mg ponesimod
Number of subjects: 326
Study 26605752 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted guide prior to visit plus decision aid during visit (arm 3)
Number of subjects: 166
Study 26605752 — intervention group
Group type: COMPARATOR
Intervention: Existing medication guide prior to clinic visit (arm 1)
Number of subjects: 166
Study 26605752 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted guide prior to visit (arm 2)
Number of subjects: 166
Study 24846909 — intervention group
Group type: EXPERIMENTAL
Intervention: Text4baby plus usual care
Number of subjects: 943
Study 24846909 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 943
Study 22158529 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised bronchodilator therapy driven by oxygen
Number of subjects: 18
Study 22158529 — intervention group
Group type: COMPARATOR
Intervention: Nebulised bronchodilator therapy driven by air
Number of subjects: 18
Study 19651523 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel
Number of subjects: 0
Study 19651523 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly docetaxel
Number of subjects: 0
Study 18773451 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean ovarian volume (MOV) threshold at 6.4 cm³
Number of subjects: 432
Study 18773451 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum ovarian volume (MaxOV) threshold at 7.9 cm³
Number of subjects: 432
Study 18773451 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean follicle number (MFN) threshold at 10
Number of subjects: 432
Study 18773451 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum follicle number (MaxFN) threshold at 12
Number of subjects: 432
Study 18773451 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian volume in PCOS patients
Number of subjects: 432
Study 18773451 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicle number in PCOS patients
Number of subjects: 432
Study 18773451 — intervention group
Group type: COMPARATOR
Intervention: Ovarian volume in controls
Number of subjects: 432
Study 18773451 — intervention group
Group type: COMPARATOR
Intervention: Follicle number in controls
Number of subjects: 432
Study 15741029 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra‐oral distraction devices
Number of subjects: 54
Study 15741029 — intervention group
Group type: COMPARATOR
Intervention: Extra‐oral distraction devices
Number of subjects: 54
Study 15741029 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study 11772601 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser in situ keratomileusis (LASIK) for low to moderate myopia
Number of subjects: 0
Study 11772601 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser in situ keratomileusis (LASIK) for moderate to high myopia (>6.0 D)
Number of subjects: 0
Study 11772601 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser in situ keratomileusis (LASIK) for mild to moderate degrees of astigmatism (<2.0 D)
Number of subjects: 0
Study 11772601 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser in situ keratomileusis (LASIK)
Number of subjects: 0
Study 10332685 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin aspart
Number of subjects: 22
Study 10332685 — intervention group
Group type: COMPARATOR
Intervention: Human insulin (injected immediately before the meal)
Number of subjects: 22
Study 10332685 — intervention group
Group type: COMPARATOR
Intervention: Human insulin (injected 30 min before the meal)
Number of subjects: 22
Study 8951251 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 73
Study 8951251 — intervention group
Group type: COMPARATOR
Intervention: Conventional mechanical ventilation
Number of subjects: 73
Study 2019357 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 57
Study 2019357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 57
Study 2019357 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 57
Study 2019357 — intervention group
Group type: COMPARATOR
Intervention: Mylanta
Number of subjects: 57
Study 31492152 — intervention group
Group type: COMPARATOR
Intervention: TAC monotherapy (n = 20)
Number of subjects: 40
Study 31492152 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC combined with MMF (n = 20)
Number of subjects: 40
Study 26796076 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic exercise
Number of subjects: 14
Study 26796076 — intervention group
Group type: COMPARATOR
Intervention: Normoxic exercise
Number of subjects: 14
Study 26796076 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (normoxic and hypoxic)
Number of subjects: 14
Study 24901809 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5 mg · kg⁻¹ of caffeine
Number of subjects: 12
Study 24901809 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg of caffeine per kg of body weight)
Number of subjects: 12
Study 22669421 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fascial sling (SISTEr trial)
Number of subjects: 1233
Study 22669421 — intervention group
Group type: EXPERIMENTAL
Intervention: Retropubic mid-urethral sling (TOMUS trial)
Number of subjects: 1233
Study 20938438 — intervention group
Group type: EXPERIMENTAL
Intervention: Lupin-enriched foods
Number of subjects: 131
Study 21602751 — intervention group
Group type: COMPARATOR
Intervention: 1% isoflurane (Group I, N=20)
Number of subjects: 40
Study 21602751 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 6 mg kg h(‐1) (Group P, N=20)
Number of subjects: 40
Study 21602751 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group I and Group P)
Number of subjects: 40
Study 17915971 — intervention group
Group type: EXPERIMENTAL
Intervention: Diurnal mood variation (DMV)
Number of subjects: 3744
Study 17915971 — intervention group
Group type: EXPERIMENTAL
Intervention: DMV
Number of subjects: 3744
Study 16142862 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular (IA) triamcinolone hexacetonide injection
Number of subjects: 69
Study 16142862 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (IM) triamcinolone acetonide mini-pulse therapy
Number of subjects: 69
Study 12096682 — intervention group
Group type: EXPERIMENTAL
Intervention: Signal/noise ratio +15
Number of subjects: 0
Study 12096682 — intervention group
Group type: COMPARATOR
Intervention: Signal/noise ratio (not specified)
Number of subjects: 0
Study 10535229 — intervention group
Group type: EXPERIMENTAL
Intervention: Iowa Strengthening Families Program (ISFP)
Number of subjects: 329
Study 10535229 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparing for the Drug‐Free Years program (PDFY)
Number of subjects: 329
Study 7572244 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-control therapy program
Number of subjects: 25
Study 7572244 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 25
Study 2338632 — intervention group
Group type: EXPERIMENTAL
Intervention: SR-verapamil fasting (1 X 240 mg)
Number of subjects: 12